We describe a new fluorogenic assay for the identification of species and intraspecies groups within the Leishmania donovani complex. The assay combined (1) 2 polymerase chain reactions targeting the 2 cysteine proteinase b isogenes and (2) a fluorescence-resonance energy transfer/melting curve analysis of the polymorphisms within a 31-nt region. All strains within the L. donovani complex were distinguished from L. tropica, L. major, and L. aethiopica, and 5 distinct groups were identified within the L. donovani complex. Discrepancies were observed with the present taxonomy on the basis of isoenzyme analysis and concerned East African strains, which suggests the need for a systematic reevaluation of the taxonomy. The capacity to type parasites directly from clinical samples was demonstrated with blood and bone marrow samples. This rapid and high-throughput alternative for molecular diagnosis and epidemiological studies of visceral leishmaniasis could be adapted for use with other Leishmania species.
rapid identification of Leishmania species and intraspecies groups.
Indeed, VL is caused by several species of the Leishmania donovani complex that differ markedly in their epidemiological characteristics. L. infantum is the etiological agent of zoonotic VL in Europe, Africa, China, and Latin America (in the latter region, it is called L. chagasi). L. donovani causes an anthroponotic form of the disease and is primarily restricted to East Africa and the Indian subcontinent, where 50% of the VL cases reported worldwide occur [1] . L. archibaldi produces zoonotic leishmaniasis in East Africa [3, 4] . The present reference method for the identification of Leishmania species is multilocus enzyme electrophoresis (MLEE) [3] . This method is isolation and cultivation dependent and is limited to specialized centers. Therefore, several polymerase chain reaction (PCR)-based methods have been developed for parasite genotyping: PCR amplification followed by restriction fragment-length polymorphism (PCR-RFLP) analysis [5] [6] [7] [8] , single-stranded conformation polymorphism (SSCP) analysis [9] , or sequence analysis [10, 11] . These methods allow a direct analysis of host samples, but they involve several steps after PCR, so use of them increases the amount of necessary equipment, the time needed for the analysis, the intensity of the labor, and the risk of DNA contamination [12, 13] . Furthermore, these methods generally do not allow high-throughput applications. Fluorogenic hybridization probes offer an attractive complement to PCR: they require only a single piece of equipment (a real-time PCR thermal cycler), and they offer the possibility for rapid and high-throughput analyses with high sensitivity [13] . In Leishmania species fluorogenic assays have so far been used primarily for detection and quantification of the pathogens [14, 15] or discrimination of Leishmania complexes [12] . One study mentions the discrimination of species [14] , but validation of the method was limited to 1 strain/species. In the present study, we developed a fluorogenic PCR assay for typing parasites of the L. donovani complex. The cysteine proteinase b (cpb) gene was selected as the target, for several reasons. First, this gene is repeated, which is important for the sensitivity of PCR detection. Second, the repeats are polymorphic [6] and are organized into 2 major groups of isogenes according to species [11] : A, B, C, or D (A-D) isogenes and E or F (E/F) isogenes. A physical map of the locus indicates that A-D isogenes are quite similar to each other, whereas A-D isogenes show 76%-78% identity with E/F isogenes [16] . Third, in a previous work, we showed that PCR-RFLP analysis of this locus was able to discriminate species and geographical populations within the L. donovani complex [6] . The discriminatory power of our fluorogenic assay was tested on a panel of strains representative of the L. donovani complex, and the assay was applied to clinical samples. Informed consent was obtained from patients or their parents or guardians, the human-experimentation guidelines of the Prins Leopold Instituut voor Tropische Geneeskunde (Antwerp, Belgium) were followed, and ethical clearance was obtained from the review boards of all institutions that provided samples. Eight human bone marrow aspirates (BMAs; collected on EDTA), 2 human venous blood samples (180 mL; collected on EDTA and mixed with an equal volume of AS1 buffer [Qiagen]), and 3 spleen aspirates from dogs were obtained. DNA was extracted using the QIAamp DNA Mini Kit, for BMAs and spleen aspirates, or the QIAamp DNA Blood Mini Kit (both from Qiagen), for venous blood samples, in accordance with the manufacturer's instructions. The detection threshold of our method was defined by processing healthy human blood containing known amounts of parasites (in concentrations ranging from to 1 L. donovani MHOM/SD/00/1S promastigote/180 4 1 ϫ 10 mL of blood) by use of the same procedures. Primers/probe design. Sequences of the cpb gene were obtained from GenBank (accession numbers AF004592, AF309626, U43706, AF309627, and AF217087). These sequences were used to design the PCR primers and the probe (table 2) with the program Primer Premier (version 5.0; Premier Biosoft Interna- ) for each polymerase chain reaction product and probe was plotted against the temperature (T), and its negative derivative (Ϫd) appeared as a positive peak (melting peak). The thick horizontal line denotes the threshold for background fluorescence, and the curve entirely below that line denotes the results for the nontemplate control. T1-6 denote the different melting peaks used to characterize the strains.
MATERIALS AND METHODS

Leishmania
tional). Two heminested PCR assays were developed: 1 for the amplification of cpbA-D and 1 for the amplification of cpbE/F. cpbA-D copies were amplified using the primer sets 7forUniv and Arev8 (first run) and PanchoCPB and Arev8 (second run).
cpbE/F copies were amplified using the primer sets 7forUniv and Dos12.1 (first run) and PanchoCPB and Dos12.1 (second run). PCR assay and fluorescence-resonance energy transfer/melting curve analysis (FRET/MCA). The PCR assay and the FRET/MCA were performed on the iCycler (Bio-Rad). The first round of each PCR was performed with a 50-mL PCR reaction mix containing 20-50 ng of DNA, 1ϫ PCR buffer, 1.0 mmol/ L (final concentration) MgCl 2 , 800 mmol/L dNTPs, 300 nmol/ limits of flocculation each primer, and 1.5 U of Taq DNA polymerase (Eurogentec). The second round of each PCR was performed with a 50-mL PCR reaction mix containing 1 mL of PCR product from the first round, 1ϫ iQ supermix buffer (BioRad), 500 nmol/L sense primer, and 100 nmol/L antisense primer. The same thermal cycling parameters were used for the first and second rounds of PCR: initial denaturation at 95ЊC for 5 min; 35 cycles consisting of denaturation at 95ЊC for 30 s, annealing at 55ЊC for 1 min, and extension at 72ЊC for 40 s; and a final extension at 72ЊC for 8 min. After the second round of PCR, the probe was added to a final concentration of 200 nmol/L for use in the FRET/MCA. The FRET/MCA was performed as follows: 95ЊC for 10 min, 65ЊC for 5 min and 10 s, and 50 cycles of 10 s during which the temperature was increased by 0.7ЊC. The assays were performed in duplicate to verify the reproducibility of the results. During the FRET/MCA, the change in the amount of fluorescence (in relative fluorescence units) for each PCR product and probe was plotted against the temperature (melting curve), and its negative derivative appeared as a positive peak (melting peak). A coefficient of variation (cv;
) was calculated for escv p 100 ϫ SD/mean timating the variation of the melting temperature (T m ) between different strains of the same species or group of parasites.
RESULTS
FRET/MCA of cpb in Leishmania strains. The FRET/MCA of cpbA-D and cpbE/F was performed for the 26 Leishmania strains. Experiments on reproducibility showed that, for a given sample, the interexperimental SD for T m was !0.4ЊC. The 3 species not in the L. donovani complex (L. tropica, L. aethiopica, and L. major) showed an amplification product during the PCR only for cpbA-D and a single melting peak characterized by a mean T m of 74.0ЊC (hereafter "T1"; cv between strains, 0.4%); there was no amplification product during the PCR for cpbE/F, because that isogene is present in only the L. donovani complex [11] . All 23 strains of the L. donovani complex had a positive signal in both cpb assays. In the assay targeting cpbA-D, a single melting peak characterized each strain, and 3 different values for T m were observed ( figure 1A ). All East African strains showed a mean T m that was undistinguishable from that of the out groups: 73.8ЊC (T1; cv, 0.4%). Two other groups were distinguished: Indian strains with a mean T m of 81.8ЊC (hereafter, "T2"; cv, 0.0%) and European strains with a mean T m of 83.0ЊC (hereafter, "T3"; cv, 0.5%). In the assay targeting cpbE/F, a single melting peak also characterized each strain, and 3 different values for T m were observed (figure 1B). Three groups were distinguished: (1) East African strains of zymodemes LON42, MON274, MON257, MON258, and MON267 and Indian strains with a mean T m of 74.2ЊC (hereafter, "T4"; cv, 0.4%); (2) European strains of zymodemes MON1, MON11, MON183, MON188, MON198, MON199, and MON228 and East African strains of zymodemes MON30, MON81, and MON82 with a mean T m of 80.2ЊC (hereafter, "T5"; cv, 0.4%); and (3) the European strain of zymodeme MON29 with a mean T m of 83.0ЊC (hereafter, "T6"). When the results of the 2 assays were combined, (1) all strains of the L. donovani complex could be distinguished from the group formed by L. tropica, L. aethiopica, and L. major, and (2) 5 groups were observed within the L. donovani complex.
FRET/MCA of cloned cpb sequence variants. To better understand the profiles observed in Leishmania strains, we cloned and sequenced cpb amplicons corresponding to the 6 melting peaks described above. Then, the FRET/MCA was performed on PCR products of the corresponding plasmids. iants were observed in the region targeted by the probe, and the same relationship between T m values and nucleotide mismatches was observed. Notably, for the region targeted by the probe, 2 of the 3 cpbA-D sequence variants (characterized by T1 and T3) corresponded to 1 of the sequence variants observed in cpbE/F (characterized by T4 and T6).
Detection threshold and clinical samples. In healthy human blood containing known amounts of L. donovani promastigotes, a positive signal was obtained in the FRET/MCA until a concentration of 0.5 and 5 parasites/mL of blood was used, respectively, in the assays targeting cpbA-D and cpbE/F. This result was expected, because there are more copies of cpbA-D than cpbE/F [16] . DNA extracted from clinical samples-5 BMAs and 2 venous blood samples from Nepalese patients, 3 BMAs from Spanish patients, and 3 spleen aspirates from Portuguese dogs, all with confirmed VL-were used to test the capability of both assays to perform a direct characterization, without isolation and culture, of the parasites. For the 13 samples, a positive signal was obtained in both assays. For the Nepalese samples, the same strain was observed, and it was found to be similar to Indian L. donovani strains ( 
DISCUSSION
In the present study, we developed a new fluorogenic probebased PCR assay for the identification of species and intraspecies groups within the L. donovani complex. The assay combines (1) 2 PCRs targeting members of the 2 different cpb isogenes (A-D and E/F) and (2) the FRET/MCA of the polymorphism within a 31-nt region common to both cpb isogenes. Within the present samples, we observed, by FRET/MCA, 3 melting peaks for each cpb isogene, and we confirmed, by sequencing, that they corresponded to different variants of the 31-nt region, some of which were shared in cpbA-D and cpbE/F isogenes. The study of each of the cpbA-D and cpbE/F isogenes allowed us to distinguish groups of strains, but the highest resolution was obtained when the results of both analyses were combined. Discrepancies were thus observed between the present taxonomy, which is based on MLEE, and our results, and these concerned East African strains of the L. donovani complex. Similar discrepancies that concerned the same strains and the same endemic region have been reported. Random amplified polymorphic DNA analysis and PCR-RFLP analysis of intragenic and intergenic regions of cpb and gp63 genes [6] and ribosomal internal transcribed spacers and miniexon genes [7] showed that strains classified as zymodeme MON30 did not cluster with L. infantum and did not support the status of zymodeme MON82 as a separate species (L. archibaldi). The convergent results obtained with non-MLEE markers strengthen the need for a systematic reevaluation of the L. donovani complex that would include epidemiological and clinical aspects [17] .
Species delineation within the L. donovani complex is relatively difficult in East Africa, which is thought to be the origin of VL [18] and where a broad continuum of genetic diversity can be observed in wild-type strains [6] . Our data fit perfectly with this perception of the genus's evolution, and they provide evidence for the following series of events in cpb gene variation. [19] . The difference described here should be validated using more strains of zymodeme MON29. This difference might be particularly relevant when considering the important role that the cpb gene plays in Leishmania virulence [16, 20] .
Finally, the capacity to type the parasites directly in clinical samples was tested with venous blood and BMAs from Nepalese and Spanish patients and spleen aspirates from Portuguese dogs, all with confirmed VL. In all samples, typing of the parasites was possible and revealed the presence of parasites similar to either Indian strains of L. donovani (Nepal) or European strains (group II) of L. infantum. A more extensive study to test the sensitivity of our assay, particularly for samples with very low parasite loads, is required. In the present format of the FRET/MCA, the parasite detection threshold-without species typing-for which cpbA-D isogene analysis was sufficient, was 0.5 parasites/mL of blood. With respect to the typing threshold, for which cpbA-D and cpbE/F isogene analysis is required, a higher parasite load was needed (5 parasites/mL of blood), because of the limiting effect of the single-copy cpbE/F isogene. These results are dependent on the performance of the PCR assay itself, which could be further optimized. However, the DNA extraction and concentration method also played a major role. We used the QIAamp DNA Blood Mini Kit, which requires a starting volume of 180 mL of blood, and other methods that use larger volumes of blood or buffy coat are likely to increase both detection and typing thresholds [21, 22] .
The FRET/MCA is a rapid, high-throughput method that can be directly applied in any laboratory equipped with a PCR setup that allows for the detection of fluorogenic probes. As such, our method represents a significant alternative for the molecular typing of Leishmania species that can be used in diagnostic and epidemiological studies. We also confirm that cpb genes are adequate targets for the FRET/MCA. These genes have also been shown to be very informative in the genetic characterization of neotropical Leishmania species [23] . Further research might include the development of a FRET/MCA that is applicable in the context of New World leishmaniasis.
